Ingevity (NGVT) Set to Announce Quarterly Earnings on Wednesday

Ingevity (NYSE:NGVT) is anticipated to post its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of $1.56 per share and revenue of $303.91 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 10:00 AM ET.

Ingevity (NYSE:NGVT) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. The firm had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. On average, analysts expect Ingevity to post $5.40 EPS for the current fiscal year and $5.90 EPS for the next fiscal year.

Ingevity Stock Performance

NGVT opened at $75.21 on Wednesday. Ingevity has a 52 week low of $45.85 and a 52 week high of $79.29. The business has a fifty day simple moving average of $70.26 and a 200-day simple moving average of $71.01.

Insider Transactions at Ingevity

In related news, SVP Ryan Fisher sold 2,709 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the sale, the senior vice president directly owned 15,722 shares in the company, valued at approximately $1,159,025.84. This represents a 14.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David Li sold 5,000 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $75.83, for a total transaction of $379,150.00. Following the completion of the sale, the chief executive officer directly owned 120,636 shares in the company, valued at approximately $9,147,827.88. This represents a 3.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,801 shares of company stock worth $1,347,481 in the last ninety days. 0.88% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on NGVT shares. Weiss Ratings cut Ingevity from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $80.00.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, efficiency, and sustainability across a range of industrial and consumer applications. Its offerings serve markets including automotive, transportation, agriculture, coatings, adhesives, pavement markings, and industrial manufacturing.

The company is best known for activated carbon products used in automotive vapor-emission control systems, where they help capture fuel vapors and reduce emissions.